3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
11
Phase 1
5
Phase NA
3
Phase 3
2
Phase 2/3
1
Phase 1/2
1
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Sarcoma
3
Conditions
Breast Neoplasms
1059
Neoplasms
885
Prostatic Neoplasms
510
Lung Neoplasms
426
Colorectal Neoplasms
358
Motor Activity
226
Uterine Cervical Neoplasms
194
Head and Neck Neoplasms
194
Carcinoma, Non-Small-Cell Lung
182
Brain Neoplasms
174
Pancreatic Neoplasms
162
Ovarian Neoplasms
143
Colonic Neoplasms
140
Carcinoma, Hepatocellular
136
Anxiety Disorders
125
Rectal Neoplasms
119
Hematologic Neoplasms
115
Multiple Myeloma
109
Stomach Neoplasms
105
Neoplasm Metastasis
100
Precursor Cell Lymphoblastic Leukemia-Lymphoma
97
Melanoma
93
Depression
93
Pain
89
Urinary Bladder Neoplasms
88
Endometrial Neoplasms
87
Glioblastoma
86
Disease
85
Lymphoma
84
Sarcoma
78
Interventions
regorafenib
1
Trabectedin
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase NA
×
Histiocytoma, Malignant Fibrous
×
1 year
×
Clear all
NCT04123535
2026-06-01
HIFU-UPS
University of California, San Francisco
Phase NA
Terminated
5 enrolled
NCT04008238
2026-03-06
PIPER
Institut Bergonié
Phase NA
Completed
29 enrolled
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled